St John Sutton M, Pfeffer MA, Plappert T, Rouleau JL, Moye LA, Dagenais GR et al (1994) Quantitative two-dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction. The protective effects of captopril. Circulation 89(1):68–75. https://doi.org/10.1161/01.cir.89.1.68

Article  CAS  PubMed  Google Scholar 

Solomon SD, Skali H, Anavekar NS, Bourgoun M, Barvik S, Ghali JK et al (2005) Changes in ventricular size and function in patients treated with valsartan, captopril, or both after myocardial infarction. Circulation 111(25):3411–3419. https://doi.org/10.1161/CIRCULATIONAHA.104.508093

Article  CAS  PubMed  Google Scholar 

Shah AM, Claggett B, Prasad N, Li G, Volquez M, Jering K et al (2022) Impact of sacubitril/valsartan compared with ramipril on cardiac structure and function after acute myocardial infarction: the PARADISE-MI echocardiographic substudy. Circulation 146(14):1067–1081. https://doi.org/10.1161/CIRCULATIONAHA.122.059210

Article  CAS  PubMed  PubMed Central  Google Scholar 

Doughty RN, Whalley GA, Walsh HA, Gamble GD, Lopez-Sendon J, Sharpe N et al (2004) Effects of carvedilol on left ventricular remodeling after acute myocardial infarction: the CAPRICORN echo substudy. Circulation 109(2):201–206. https://doi.org/10.1161/01.CIR.0000108928.25690.94

Article  CAS  PubMed  Google Scholar 

McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Bohm M et al (2021) 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 42(36):3599–3726. https://doi.org/10.1093/eurheartj/ehab368

Article  CAS  PubMed  Google Scholar 

McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Bohm M et al (2023) 2023 focused update of the 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 44(37):3627–3639. https://doi.org/10.1093/eurheartj/ehad195

Article  CAS  PubMed  Google Scholar 

von Lewinski D, Kolesnik E, Tripolt NJ, Pferschy PN, Benedikt M, Wallner M et al (2022) Empagliflozin in acute myocardial infarction: the EMMY trial. Eur Heart J 43(41):4421–4432. https://doi.org/10.1093/eurheartj/ehac494

Article  CAS  Google Scholar 

Byrne RA, Rossello X, Coughlan JJ, Barbato E, Berry C, Chieffo A et al (2023) 2023 ESC guidelines for the management of acute coronary syndromes. Eur Heart J 44(38):3720–3826. https://doi.org/10.1093/eurheartj/ehad191

Article  CAS  PubMed  Google Scholar 

Tripolt NJ, Kolesnik E, Pferschy PN, Verheyen N, Ablasser K, Sailer S et al (2020) Impact of EMpagliflozin on cardiac function and biomarkers of heart failure in patients with acute MYocardial infarction—the EMMY trial. Am Heart J 221:39–47. https://doi.org/10.1016/j.ahj.2019.12.004

Article  CAS  PubMed  Google Scholar 

Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L et al (2015) Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 28(1):1-39.e14. https://doi.org/10.1016/j.echo.2014.10.003

Article  PubMed  Google Scholar 

Nagueh SF, Smiseth OA, Appleton CP, Byrd BF 3rd, Dokainish H, Edvardsen T et al (2016) Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 17(12):1321–1360. https://doi.org/10.1093/ehjci/jew082

Article  PubMed  Google Scholar 

Rudski LG, Lai WW, Afilalo J, Hua L, Handschumacher MD, Chandrasekaran K et al (2010) Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr 23(7):685–713. https://doi.org/10.1016/j.echo.2010.05.010

Article  PubMed  Google Scholar 

Galie N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A et al (2016) 2015 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension: the joint task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J 37(1):67–119. https://doi.org/10.1093/eurheartj/ehv317

Article  PubMed  Google Scholar 

Voigt JU, Pedrizzetti G, Lysyansky P, Marwick TH, Houle H, Baumann R et al (2015) Definitions for a common standard for 2D speckle tracking echocardiography: consensus document of the EACVI/ASE/Industry Task Force to standardize deformation imaging. J Am Soc Echocardiogr 28(2):183–193. https://doi.org/10.1016/j.echo.2014.11.003

Article  PubMed  Google Scholar 

Sugimoto T, Dulgheru R, Bernard A, Ilardi F, Contu L, Addetia K et al (2017) Echocardiographic reference ranges for normal left ventricular 2D strain: results from the EACVI NORRE study. Eur Heart J Cardiovasc Imaging 18(8):833–840. https://doi.org/10.1093/ehjci/jex140

Article  PubMed  Google Scholar 

Badano LP, Kolias TJ, Muraru D, Abraham TP, Aurigemma G, Edvardsen T et al (2018) Standardization of left atrial, right ventricular, and right atrial deformation imaging using two-dimensional speckle tracking echocardiography: a consensus document of the EACVI/ASE/Industry Task Force to standardize deformation imaging. Eur Heart J Cardiovasc Imaging 19(6):591–600. https://doi.org/10.1093/ehjci/jey042

Article  PubMed  Google Scholar 

Tsao CW, Aday AW, Almarzooq ZI, Anderson CAM, Arora P, Avery CL et al (2023) Heart disease and stroke statistics-2023 update: a report from the American Heart Association. Circulation 147(8):e93–e621. https://doi.org/10.1161/CIR.0000000000001123

Article  PubMed  Google Scholar 

Greenberg B, Quinones MA, Koilpillai C, Limacher M, Shindler D, Benedict C et al (1995) Effects of long-term enalapril therapy on cardiac structure and function in patients with left ventricular dysfunction. Results of the SOLVD echocardiography substudy. Circulation 91(10):2573–2581. https://doi.org/10.1161/01.cir.91.10.2573

Article  CAS  PubMed  Google Scholar 

Groenning BA, Nilsson JC, Sondergaard L, Fritz-Hansen T, Larsson HB, Hildebrandt PR (2000) Antiremodeling effects on the left ventricle during beta-blockade with metoprolol in the treatment of chronic heart failure. J Am Coll Cardiol 36(7):2072–2080. https://doi.org/10.1016/s0735-1097(00)01006-8

Article  CAS  PubMed  Google Scholar 

Frantz S, Hundertmark MJ, Schulz-Menger J, Bengel FM, Bauersachs J (2022) Left ventricular remodelling post-myocardial infarction: pathophysiology, imaging, and novel therapies. Eur Heart J 43(27):2549–2561. https://doi.org/10.1093/eurheartj/ehac223

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hoshika Y, Kubota Y, Mozawa K, Tara S, Tokita Y, Yodogawa K et al (2021) Effect of empagliflozin versus placebo on plasma volume status in patients with acute myocardial infarction and type 2 diabetes mellitus. Diabetes Ther 12(8):2241–2248. https://doi.org/10.1007/s13300-021-01103-0

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lee MMY, Brooksbank KJM, Wetherall K, Mangion K, Roditi G, Campbell RT et al (2021) Effect of empagliflozin on left ventricular volumes in patients with type 2 diabetes, or prediabetes, and heart failure with reduced ejection fraction (SUGAR-DM-HF). Circulation 143(6):516–525. https://doi.org/10.1161/CIRCULATIONAHA.120.052186

Article  CAS  PubMed  Google Scholar 

Wei W, Liu J, Chen S, Xu X, Guo D, He Y et al (2022) Sodium glucose cotransporter type 2 inhibitors improve cardiorenal outcome of patients with coronary artery disease: a meta-analysis. Front Endocrinol 13:850836. https://doi.org/10.3389/fendo.2022.850836

Article  Google Scholar 

Paolisso P, Bergamaschi L, Santulli G, Gallinoro E, Cesaro A, Gragnano F et al (2022) Infarct size, inflammatory burden, and admission hyperglycemia in diabetic patients with acute myocardial infarction treated with SGLT2-inhibitors: a multicenter international registry. Cardiovasc Diabetol 21(1):77. https://doi.org/10.1186/s12933-022-01506-8

Article  CAS  PubMed  PubMed Central  Google Scholar 

James S, Erlinge D, Storey RF, McGuire DK, de Belder M, Eriksson N et al (2023) Dapagliflozin in myocardial infarction without diabetes or heart failure. NEJM Evidence. https://doi.org/10.1056/EVIDoa2300286

Article  PubMed  Google Scholar 

Butler J, Jones WS, Udell JA, Anker SD, Petrie MC, Harrington J et al (2024) Empagliflozin after acute myocardial infarction. N Engl J Med 390(16):1455–1466. https://doi.org/10.1056/NEJMoa2314051

Article  CAS  PubMed